Leaderboard

En | De
Sie sind hier: Psychiatrie » Schizophrenie und Psychosen 11. Mai 2021
Suchen
medline.ch
Schizophrenie und Psychosen
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Angst- und Panikstörungen
Demenz
Depression
Essstörungen
Persönlichkeits- störungen
Schizophrenie und Psychosen
Schlafstörungen
Sexuelle Störungen
Somatoforme Störungen
Sucht
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2757  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 55128  
   
Cognitive impairment profile in adolescent early-onset psychosis using the MATRICS Battery: Age and sex effects.
Neuropsychology
Smelror RE, Johannessen C, Wedervang-Resell K, Jørgensen KN, Barth C, Andreou D, Ueland T, Andreassen OA, Myhre AM, Rund BR, Agartz I.
PMID: 33970663 [PubMed - as supplied by publisher]


Efficacy and Safety of Lurasidone in Adolescents and Young Adults with Schizophrenia: A Pooled Post-hoc Analysis of Double-Blind, Placebo-Controlled 6-Week Studies.
Eur Psychiatry
Costamagna I, Calisti F, Cattaneo A, Hsu J, Tocco M, Pikalov A, Goldman R.
PMID: 33966678 [PubMed - as supplied by publisher]


Relationship between satisfaction with mental health services, personal recovery and quality of life among service users with psychosis: a cross-sectional study.
BMC Health Serv Res
Skar-Fröding R, Clausen HK, , Ruud T, Slade M, Sverdvik Heiervang K.
PMID: 33964917 [PubMed - in process]


Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
J Psychiatr Res
Kishi T, Ikuta T, Sakuma K, Okuya M, Iwata N.
PMID: 33964682 [PubMed - as supplied by publisher]


Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study.
Schizophr Bull
Ajnakina O, Rodriguez V, Quattrone D, di Forti M, Vassos E, Arango C, Berardi D, Bernardo M, Bobes J, de Haan L, Del-Ben CM, Gayer-Anderson C, Jongsma HE, Lasalvia A, Tosato S, Llorca PM, Menezes PR, Rutten BP, Santos JL, Sanjuán J, Selten JP, Szöke A, Tarricone I, D'Andrea G, Richards A, Tortelli A, Velthorst E, Jones PB, Arrojo Romero M, La Cascia C, Kirkbride JB, van Os J, O'Donovan M, Murray RM, EU-GEI WP2 Group..
PMID: 33963865 [PubMed - as supplied by publisher]


Abnormal Gesture Perception and Clinical High-Risk for Psychosis.
Schizophr Bull
Gupta T, Osborne KJ, Mittal VA.
PMID: 33963750 [PubMed - as supplied by publisher]


Mediating effect of empowerment on the relationship between global function and personal recovery among community-dwelling patients with schizophrenia: a cross-sectional study.
BMC Psychiatry
Lee KT, Lee SK, Lu MJ, Hsieh WL, Liu WI.
PMID: 33962596 [PubMed - in process]


Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
Psychiatry Res
Medalia A, Saperstein AM, Stefancic A, Meyler S, Styke S, Qian M, Liu J, Cabassa LJ.
PMID: 33962354 [PubMed - as supplied by publisher]


Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study.
Asian J Psychiatr
Miyaoka T, Wake R, Araki T, Inoue K, Horiguchi J.
PMID: 33962269 [PubMed - as supplied by publisher]


The efficacy and acceptability of hybrid electroconvulsive therapy compared with standard electroconvulsive therapy for schizophrenia patients: A parallel-group, double-blind, randomized, controlled trial.
Brain Stimul
Li J, Deng WF, Xu SX, Jiang ZY, Rong H, Kong XM, Xie XH.
PMID: 33962078 [PubMed - as supplied by publisher]


The limited effect of neural stimulation on visual attention and social cognition in individuals with schizophrenia.
Neuropsychologia
Klein HS, Vanneste S, Pinkham AE.
PMID: 33961863 [PubMed - as supplied by publisher]


Peer support in early intervention in psychosis: a qualitative research study.
J Ment Health
Nguyen J, Goldsmith L, Rains LS, Gillard S.
PMID: 33961753 [PubMed - as supplied by publisher]


Disentangling age- and disease-related alterations in schizophrenia brain network using structural equation modeling: A graph theoretical study based on minimum spanning tree.
Hum Brain Mapp
Liu X, Yang H, Becker B, Huang X, Luo C, Meng C, Biswal B.
PMID: 33960579 [PubMed - as supplied by publisher]


Neural Correlates of Mentalizing in Individuals With Clinical High Risk for Schizophrenia: ALE Meta-Analysis.
Front Psychiatry
Vucurovic K, Caillies S, Kaladjian A.
PMID: 33959048 [PubMed]


Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia.
Front Pharmacol
Willcocks IR, Legge SE, Nalmpanti M, Mazzeo L, King A, Jansen J, Helthuis M, Owen MJ, O'Donovan MC, Walters JTR, Pardiñas AF.
PMID: 33959025 [PubMed]


Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia.
Transl Psychiatry
Parellada E, Gassó P.
PMID: 33958577 [PubMed - in process]


Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study.
Int J Ment Health Syst
Moges S, Belete T, Mekonen T, Menberu M.
PMID: 33957944 [PubMed]


Use of mouse models to investigate the contributions of CNVs associated with schizophrenia and autism to disease mechanisms.
Curr Opin Genet Dev
Hyman SE.
PMID: 33957550 [PubMed - as supplied by publisher]


Classification of first-episode psychosis using cortical thickness: A large multicenter MRI study.
Eur Neuropsychopharmacol
Pigoni A, Dwyer D, Squarcina L, Borgwardt S, Crespo-Facorro B, Dazzan P, Smesny S, Spaniel F, Spalletta G, Sanfelici R, Antonucci LA, Reuf A, Oeztuerk OF, Schmidt A, Ciufolini S, Schönborn-Harrisberger F, Langbein K, Gussew A, Reichenbach JR, Zaytseva Y, Piras F, Delvecchio G, Bellani M, Ruggeri M, Lasalvia A, Tordesillas-Gutiérrez D, Ortiz V, Murray RM, Reis-Marques T, Di Forti M, Koutsouleris N, Brambilla P, ClassiFEP group..
PMID: 33957410 [PubMed - as supplied by publisher]


Effects of khat use on response to antipsychotic medications in patients with newly diagnosed schizophrenia: a retrospective study.
East Mediterr Health J
Hakami T, Mahmoud M, Mohammed B, El-Setouhy M.
PMID: 33955531 [PubMed - in process]


   
   Artikel 1 - 20 / 55128    Seite 1 von 2757  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

  Zeitfenster  
   

Sky right 1